Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the phenylpyrimidine class of organic compounds. It features a pyrimidine core substituted with aminomethyl and dichlorophenyl groups as well as a dimethoxyphenyl moiety. The compound is listed in chemical and drug databases such as DrugBank (DB02004), ChEMBL (CHEMBL34062), and ZINC (ZINC000003817007). It has been classified as an experimental molecule with no approved therapeutic indications or established mechanism of action. There is no evidence that it has reached clinical development or been assigned to any pharmaceutical developer or manufacturer[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine.